written on 08.04.2014

Takeda strengthens cancer focus with Mersana ADC deal

TAGS: ,

Takeda is ramping up its presence in oncology, having signed a deal with antibody-drug conjugate (ADC) specialist Mersana Therapeutics via subsidiary Millennium Pharmaceuticals.